Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Botox for Poststroke Spasticity
NCT00651729Phase 2Completed
- Sponsor
- Allergan
- Start
- Apr 2003
- Primary completion
- Dec 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of onabotulinumtoxinA in Spasticity, sponsored by Allergan. Started Apr 2003; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT00651729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00651729.